Oculis Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.5%.

Top 20 shareholders own 44.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.6%	LSP Advisory B.V.,	7,324,664	US$87.2m	0%	82.76%
5.6%	Landsbréf Hf.	2,335,841	US$27.8m	0%	58.99%
4.96%	BVCF Management Ltd	2,070,020	US$24.6m	0%	49.81%
4.87%	Pivotal BioVenture Partners LLC	2,032,296	US$24.2m	-15.6%	9.77%
3.2%	Novartis Venture Funds	1,335,492	US$15.9m	-24.8%	100.0%
2.94%	abrdn plc	1,228,042	US$14.6m	-15.5%	0.01%
2.1%	Riad Sherif	878,486	US$10.5m	0%	no data
1.24%	Chen's Group International Limited	516,470	US$6.1m	0%	no data
0.91%	Novartis AG	378,029	US$4.5m	-5.9%	no data
0.6%	Páll Jóhannesson	249,224	US$3.0m	0%	no data
0.23%	Anthony Rosenberg	96,670	US$1.2m	0%	no data
0.23%	Lombard Odier Darier Hentsch & Cie Asset Management	95,750	US$1.1m	0%	0.02%
0.16%	Sylvia Cheung	66,808	US$795.0k	0%	no data
0.048%	Merrill Lynch & Co. Inc., Banking Investments	19,894	US$236.7k	17.5%	no data
0.036%	Geode Capital Management, LLC	14,944	US$177.8k	118%	no data
0.028%	Christina Ackermann	11,718	US$139.4k	0%	no data
0.022%	State Street Global Advisors, Inc.	9,144	US$108.8k	-0.61%	no data
0.0026%	UBS Asset Management AG	1,097	US$13.1k	0%	no data
0.00001%	DuPont Capital Management Corporation	4	US$49.7	0%	no data
0%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$0	0%	no data